Nitric oxide-assisted mucus-walking zwitterionic nanocomplexes for synergistic treatment of severe respiratory infectious disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Kyungtae | - |
dc.contributor.author | Jung, Sungwon | - |
dc.contributor.author | Lee, Hye-Jin | - |
dc.contributor.author | Nam, Hyangsu | - |
dc.contributor.author | Heo, Sungeun | - |
dc.contributor.author | Oh, Yoogyeong | - |
dc.contributor.author | Won Park, Chai | - |
dc.contributor.author | Kim, Jungbum | - |
dc.contributor.author | Hong Ahn, June | - |
dc.contributor.author | Bum Lee, Jong | - |
dc.contributor.author | Hwang, Patrick T.J. | - |
dc.contributor.author | Lee, Sangmin | - |
dc.contributor.author | Lee, Wonhwa | - |
dc.contributor.author | Hong, Jinkee | - |
dc.date.accessioned | 2024-02-08T05:30:29Z | - |
dc.date.available | 2024-02-08T05:30:29Z | - |
dc.date.issued | 2024-01 | - |
dc.identifier.issn | 1369-7021 | - |
dc.identifier.issn | 1873-4103 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/71868 | - |
dc.description.abstract | Among patients who suffer from lung-related disability, acute respiratory distress syndrome (ARDS) is one of the diseases with the significant mortality rate and the main cause is the interference in pulmonary drug delivery by accumulated bronchoalveolar lavage fluid (BALF) in the alveolar region. Here, a zwitterion-functionalized multi-drug nanocomplex (ZnC) capable of anti-mucociliary clearance was synthesized. Additionally, nitric oxide (NO) was functionalized with ZnC to fuel the mobility in the BALF through its role as a nanomotor as well as anti-inflammation. Subsequently, dexamethasone (Dex) was loaded and final product of anti-inflammatory mucus permeator (AIM) was introduced. By in situ tracking the AIM within the mucus-rich environment, the fueled mobility by NO and zwitterion was demonstrated. Notably, when AIM was inhaled by the in vivo ARDS model, there was an increase in the anti-inflammation effect due to the presence of ZnC as well as the synergy between NO and Dex, which recovered the pulmonary function of the model and increased survival rate. © 2023 Elsevier Ltd | - |
dc.format.extent | 14 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier B.V. | - |
dc.title | Nitric oxide-assisted mucus-walking zwitterionic nanocomplexes for synergistic treatment of severe respiratory infectious disease | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.mattod.2023.11.011 | - |
dc.identifier.bibliographicCitation | Materials Today, v.72, pp 57 - 70 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 001206926800001 | - |
dc.identifier.scopusid | 2-s2.0-85180474819 | - |
dc.citation.endPage | 70 | - |
dc.citation.startPage | 57 | - |
dc.citation.title | Materials Today | - |
dc.citation.volume | 72 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Acute respiratory distress syndrome | - |
dc.subject.keywordAuthor | Anti-inflammation | - |
dc.subject.keywordAuthor | Mobility in mucus | - |
dc.subject.keywordAuthor | Nitric oxide nanomotor | - |
dc.subject.keywordAuthor | Zwitterion | - |
dc.subject.keywordPlus | PULMONARY DELIVERY | - |
dc.subject.keywordPlus | PENETRATING NANOPARTICLES | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | DRUGS | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Multidisciplinary | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.